1. Home
  2. EVH vs IOVA Comparison

EVH vs IOVA Comparison

Compare EVH & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVH
  • IOVA
  • Stock Information
  • Founded
  • EVH 2011
  • IOVA 2007
  • Country
  • EVH United States
  • IOVA United States
  • Employees
  • EVH N/A
  • IOVA N/A
  • Industry
  • EVH Other Consumer Services
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EVH Consumer Discretionary
  • IOVA Health Care
  • Exchange
  • EVH Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • EVH 1.2B
  • IOVA 771.4M
  • IPO Year
  • EVH 2015
  • IOVA N/A
  • Fundamental
  • Price
  • EVH $11.38
  • IOVA $1.92
  • Analyst Decision
  • EVH Strong Buy
  • IOVA Buy
  • Analyst Count
  • EVH 14
  • IOVA 10
  • Target Price
  • EVH $16.79
  • IOVA $12.22
  • AVG Volume (30 Days)
  • EVH 3.3M
  • IOVA 10.7M
  • Earning Date
  • EVH 08-07-2025
  • IOVA 08-07-2025
  • Dividend Yield
  • EVH N/A
  • IOVA N/A
  • EPS Growth
  • EVH N/A
  • IOVA N/A
  • EPS
  • EVH N/A
  • IOVA N/A
  • Revenue
  • EVH $2,398,737,000.00
  • IOVA $212,679,000.00
  • Revenue This Year
  • EVH N/A
  • IOVA $86.62
  • Revenue Next Year
  • EVH $16.14
  • IOVA $69.95
  • P/E Ratio
  • EVH N/A
  • IOVA N/A
  • Revenue Growth
  • EVH 10.24
  • IOVA 11070.12
  • 52 Week Low
  • EVH $7.06
  • IOVA $1.64
  • 52 Week High
  • EVH $33.63
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • EVH 65.62
  • IOVA 54.54
  • Support Level
  • EVH $10.86
  • IOVA $1.85
  • Resistance Level
  • EVH $12.07
  • IOVA $2.02
  • Average True Range (ATR)
  • EVH 0.49
  • IOVA 0.11
  • MACD
  • EVH -0.01
  • IOVA 0.04
  • Stochastic Oscillator
  • EVH 62.47
  • IOVA 97.44

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: